{
    "Trade/Device Name(s)": [
        "Elecsys CMV IgG Immunoassay",
        "Elecsys PreciControl CMV IgG"
    ],
    "Submitter Information": "Roche Diagnostics",
    "510(k) Number": "K131605",
    "Predicate Device Reference 510(k) Number(s)": [
        "K981163",
        "K072617"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LFZ",
        "JJX"
    ],
    "Summary Letter Date": "January 28, 2014",
    "Summary Letter Received Date": "January 29, 2014",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 866.3175"
    ],
    "Regulation Name(s)": [
        "Cytomegalovirus serological reagents"
    ],
    "Analyte Class(es)": [
        "immunology",
        "virology"
    ],
    "Analyte(s)": [
        "CMV IgG antibodies"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Lithium-heparin plasma",
        "K2-EDTA plasma",
        "K3-EDTA plasma"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Elecsys 2010",
        "MODULAR ANALYTICS E170",
        "cobas e 411",
        "cobas e 601",
        "cobas e 602"
    ],
    "Method(s)/Technology(ies)": [
        "Electrochemiluminescence immunoassay (ECLIA)",
        "Sandwich assay"
    ],
    "Methodologies": [
        "Immunoassay"
    ],
    "Submission Type(s)": [
        "Assay",
        "Quality control material"
    ],
    "Document Summary": "FDA 510(k) summary for Elecsys CMV IgG Immunoassay and Elecsys PreciControl CMV IgG for detection and quality control of CMV IgG antibodies using ECLIA technology",
    "Indications for Use Summary": "Qualitative detection of IgG antibodies to CMV in serum and plasma specimens as an aid in determination of serological status to CMV, including use in pregnant women; PreciControl CMV IgG for assay quality control.",
    "fda_folder": "Microbiology"
}